Cargando…
Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse
BACKGROUND: HPV-related cervical cancer (CC) is the fourth most frequent cancer in women worldwide. Cell-free tumour DNA is a potent biomarker to detect treatment response, residual disease, and relapse. We investigated the potential use of cell-free circulating HPV-DNA (cfHPV-DNA) in plasma of pati...
Autores principales: | Mittelstadt, Suzana, Kelemen, Olga, Admard, Jakob, Gschwind, Axel, Koch, André, Wörz, Sarah, Oberlechner, Ernst, Engler, Tobias, Bonzheim, Irina, Staebler, Annette, Weidner, Nicola, Stubenrauch, Frank, Iftner, Thomas, Riess, Olaf, Schroeder, Christopher, Kommoss, Stefan, Ossowski, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206065/ https://www.ncbi.nlm.nih.gov/pubmed/36973448 http://dx.doi.org/10.1038/s41416-023-02233-x |
Ejemplares similares
-
TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy
por: Eckardt, Julia, et al.
Publicado: (2022) -
HPV Detection Methods
por: Brink, Antoinette A. T. P., et al.
Publicado: (2007) -
HPV-EM: an accurate HPV detection and genotyping EM algorithm
por: Inkman, Matthew J., et al.
Publicado: (2020) -
A case of recurrent respiratory papillomatosis with malignant transformation, HPV11 DNAemia, high L1 antibody titre and a fatal papillary endocardial lesion
por: Mauz, Paul-Stefan, et al.
Publicado: (2014) -
Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients
por: Hilke, Franz J., et al.
Publicado: (2020)